Track 1: General Virology

Virology is the investigation of viral – sub microscopic, parasitic particles of hereditary material contained in a protein coat and virus-like specialists. It centres around the accompanying parts of infections: their structure, order and development, their approaches to contaminating and misuse have cells for propagation, their cooperation with have living being's physiology and insusceptibility, the ailments they cause, the methods to seclude and culture them, and their utilization in research and treatment. Virology is viewed as a subfield of microbiology or of medication.

Track 2: Viral Immunology

Viral immunology is the investigation of viral contaminations and safe reactions toward viral diseases which can cause an injurious impact on the elements of the cells. It incorporates both DNA and RNA viral contaminations. Infections are firmly immunogenic and incite 2 sorts of resistant reactions; humoral and cell. The collection of specificities of T and B cells is shaped by revisions and substantial transformations. T and B cells don't, for the most part, perceive similar epitopes present on a similar infection. B cells see the free unaltered proteins in their local 3-D compliance through T cells, for the most part, observe the Ag in a denatured structure related to MHC particles. The qualities of the safe response to a similar infection may vary in various people contingent upon their hereditary constitutions.

Track 3: Molecular and Cellular Virology 

Molecular and cellular virology is the investigation of infections on a sub-molecular level. Infections are submicroscopic parasites that duplicate inside host cells. They can effectively contaminate and parasitize a wide range of life structures from microorganisms to plants and creatures and accordingly, infections have more organic decent variety than the remainder of the bacterial, plant, and creature realms consolidated. Considering this decent variety is the way to a superior comprehension of how infections collaborate with their hosts, imitate inside them, and cause illnesses.

Track 4: Vaccine Research and Development

Vaccine Research (IVR) encourage immunization innovative work (R&D) against pathogens with noteworthy malady and monetary weight, with a specific spotlight on low and centre salary nations. For example, the assistance of beginning period R&D in ailment territories with no accessible antibodies or problematic immunizations, research to upgrade general wellbeing sway where existing antibodies are underutilized, research to help presentation dynamic and post-licensure appraisals of hazard/advantage research to improve observing and assessment of antibodies being used in vaccination programs.

Track 5: Viral Vaccines

Immunizations that are created from viruses are viral antibodies. Viral immunizations contain either inactivated infections or lessened infections. One of the most well-known instances of viral immunization is MMR (mumps, measles, and rubella) antibody. Inactivated or murdered viral antibodies contain infections, which have lost their capacity to imitate and thusly cause malady.

Track 6: Bacterial and Fungal Virology

The investigation of parasites that increase inside bacterias by utilizing the host biosynthetic hardware is known as bacterial virology. Bacteriophages are the infections that taint and duplicate in microscopic organisms. Since the mid-1970s, microscopic organisms have kept on creating protection from anti-toxins, for example, penicillin, and this has prompted a restored enthusiasm for the utilization of bacteriophages to treat genuine diseases. It manages infections that contaminate parasites known as Mycoviruses. Mycoviruses have twofold stranded RNA genomes and isometric particles, yet about 30% of them have positive sense and single-stranded RNA genomes, to be genuine Mycoviruses, they should have a capacity to be transmitted (at the end of the day have the option to taint other solid growths).

Track 7: Microbiology

Microbiology is the investigation of minute creatures, for example, microscopic organisms, infections, archaea, growths, and protozoa. This control remembers key research for natural chemistry, physiology, cell science, biology, development, and clinical parts of microorganisms, including the host reaction to these specialists.

Track 8: Human Vaccines- Infectious and Non-Infectious Diseases

More usage of Vaccines has decreased the infectious and non-infectious diseases among infants and adults. Many chronic infectious and non-infectious diseases are highly treated using recent technologies and advanced research in monoclonal antibodies. The present challenge in the vaccination world is to develop vaccines for diseases that will consistently maintain the antibody responses in the human body. Some Vaccines give immunity over life whereas some require booster shots. However, currently developing vaccines were more likely to develop effective immunity.

Track 9: Veterinary Vaccines

Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. Both animals kept as pets and animals raised as livestock are routinely vaccinated. In some instances, wild populations may be vaccinated. The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase the production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife.

Track 10: Virology and Infectious Diseases

Virology is the study of viruses and virus-like agents, including their taxonomy, disease-producing properties, cultivation, and genetics. Virology focuses on the attributes of viruses, such as their structure, how they are classified, and how they are being evolved. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans.

Virology, the study of viruses, is an unparalleled branch of life sciences. With an immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global medicine market is anticipated to grow over 2015-2025. The major players are expected to remain key growth drivers for virology over the study amount because of hyperbolic instances of microorganism epidemic breakouts and large investment in analysis and Development.

Some of the astonishing discoveries are Antiviral agents for the treatment of Ebola virus disease, Kidney transplantation from HIV-positive donor to HIV-positive recipient, Gene editing of the HIV receptor, Indeterminate HIV nucleic acid test leads to infants, Modified vaccinia Ankara vaccine for prevention of smallpox, Outcomes for Zika virus-exposed infants in the second year of life.

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the largest medicine market junction rectifier by the U.S., owing to technological advancements such as rapid, portable diagnostics. North America is predicted to retain the highest market position over the forecast period also. Globally Europe is projected to maintain the position as the second-largest market. Throughout the forecast period, Europe is estimated to record the highest CAGR, recognized by enhanced healthcare infrastructure, growing affordability of diagnostic tests for viral diseases and facilitated access to diagnostics.